Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2011
10/06/2011WO2011123041A1 Fertilization prediction and promotion
10/06/2011WO2011123021A1 Method for determining the amount of dntp
10/06/2011WO2011122859A2 Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same
10/06/2011WO2011122857A2 Composition for predicting prognosis of breast cancer, and kit containing same
10/06/2011WO2011122634A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma
10/06/2011WO2011122501A1 Method for distinguishing target base sequence
10/06/2011WO2011122034A1 Method for detecting pneumonia causative bacteria using nucleic acid chromatography
10/06/2011WO2011122021A1 Marker for prediction of recurrence of hepatocellular carcinoma
10/06/2011WO2011121881A1 Biopolymer analysis method, biopolymer analyzer, and biopolymer analysis chip
10/06/2011WO2011121610A1 Micrornas (mirna) as biomarkers for detecting different grades of gliomas and pathways of glioma progression
10/06/2011WO2011121544A1 Peptide nucleicacid probe, kit and method for detection and/or quantification of salmonella spp. and applications thereof
10/06/2011WO2011121288A2 Assays for candida glabrata
10/06/2011WO2011121028A1 Algorithm for prediction of benefit from addition of taxane to standard chemotherapy in patients with breast cancer
10/06/2011WO2011120984A1 Method for breast cancer recurrence prediction under endocrine treatment
10/06/2011WO2011120964A1 System and method to correct out of phase errors in dna sequencing data by use of a recursive algorithm
10/06/2011WO2011120885A1 Hcv ns5a replicon shuttle vectors
10/06/2011WO2011120556A1 Composition for the determination of coagulation characteristics of a test liquid
10/06/2011WO2011120409A1 Method for detecting gene region features based on inter-alu polymerase chain reaction
10/06/2011WO2011120398A1 Joint detection method for leukemia fusion genes and diagnostic kits thereof
10/06/2011WO2011120332A1 Double-stranded rna molecules with stability in mammalian body fluid, preparation and application thereof
10/06/2011WO2011120165A1 Macrocyclic lactone resistance marker for dirofilaria immitis
10/06/2011WO2011120101A1 Small rna molecules and methods of use
10/06/2011WO2011120099A1 Diagnostic and prognostic methods for cancer
10/06/2011WO2011120072A1 A method of regulating oligonucleotide functionality
10/06/2011WO2011100369A3 Methods for altering polypeptide expression and solubility
10/06/2011WO2011098262A3 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
10/06/2011WO2011094806A8 Diagnostic and prognostic assay for breast cancer
10/06/2011WO2011086174A3 Diagnostic gene expression platform
10/06/2011WO2011085288A3 Method of administration and treatment
10/06/2011WO2011081945A3 Activation and activators of sirt6
10/06/2011WO2011079277A3 Genetic markers associated with drought tolerance in maize
10/06/2011WO2011077087A3 Method of establishing a fungal nail infection
10/06/2011WO2011066571A3 Assays for mutagenesis detection
10/06/2011WO2011059508A3 Methods for pcr and hla typing using raw blood
10/06/2011WO2011059285A3 Genotyping method
10/06/2011WO2011056688A3 Molecular profiling for personalized medicine
10/06/2011WO2011056687A3 Bimolecular primers
10/06/2011WO2011053864A3 Bacterial metastructure and methods of use
10/06/2011WO2011037643A3 Compositions and methods for detecting and treating prostate carcinoma
10/06/2011WO2011034935A3 Transcription biomarkers of biological responses and methods
10/06/2011WO2011034397A3 Method for predicting drug targets and screening for drugs for pathogenic microorganisms using essential metabolites
10/06/2011WO2011032155A3 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
10/06/2011WO2011029881A3 A method for binding a recombinant polypeptide to a carrier
10/06/2011WO2011019815A3 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
10/06/2011WO2011011062A3 Flow cell device
10/06/2011WO2009100489A8 Crystal structure of pfa-mi and the pfa-mi co4 complex
10/06/2011WO2008133643A8 Plant micrornas and methods of use thereof
10/06/2011US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2011US20110247094 Transgenic Plants with Enhanced Agronomic Traits
10/06/2011US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011US20110246413 Method for judging risk of cancer recurrence, computer program, and computer system
10/06/2011US20110245492 Novel allelic variant of cyp2c19 associated with drug metabolism
10/06/2011US20110245482 Non-invasive detection of fetal genetic traits
10/06/2011US20110245462 Non-Fluorescent Quencher Compounds and Biomolecular Assays
10/06/2011US20110245352 Composition For Permeabilizing The Walls Of Microorganisms Comprising The Combination Of Ethylenediaminetetraacetic Acid (EDTA) And Polyethyleneimine (PEI)
10/06/2011US20110245340 Screening Method for Identifying Patients at Risk of Adverse Hepatologic Events
10/06/2011US20110245331 Inhibitors of epoxide hydrolases for the treatment of hypertension
10/06/2011US20110245328 HCV NS5A Replicon Shuttle Vectors
10/06/2011US20110245327 Oligonucleotide Analogues
10/06/2011US20110245325 Pharmaceutical composition for treatment of cancer and asthma
10/06/2011US20110245324 Antimicrobial compounds
10/06/2011US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011US20110245309 N-methylpurine dna glycosylase and polymerase beta as biomarkers for alkylator chemotherapy potentiation
10/06/2011US20110245217 Methods for diagnosing and treating asthma
10/06/2011US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011US20110245150 Targets for treatment of chlamydial infections
10/06/2011US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011US20110245107 Selective differentiation, identification, amd modulation of human th17 cells
10/06/2011US20110245104 Method for screening the sensitizing properties of chemical compounds
10/06/2011US20110245102 Gene Expression Profiling of EGFR Positive Cancer
10/06/2011US20110245096 Compositions and methods for the treatment of immune related diseases
10/06/2011US20110245095 Fast assignment of adequate chemotherapy with latinum based drugs for cancer patients based on the identification of constitutional brcal mutations
10/06/2011US20110245091 Reaction progress assay for screening biological activity of enzymes
10/06/2011US20110245090 Compositions and methods for the treatment of immune related diseases
10/06/2011US20110245089 Laboratory central control unit method and system
10/06/2011US20110245087 Method for optimizing and validating an assay for determining the presence or absence of a medical condition
10/06/2011US20110245086 Short cycle methods for sequencing polynucleotides
10/06/2011US20110245085 Methods for determining copy number variations
10/06/2011US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/06/2011US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011US20110244548 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties
10/06/2011US20110244514 Mammalian Sweet Taste Receptors
10/06/2011US20110244511 Methods and articles for detecting hemolytic microorganisms
10/06/2011US20110244510 Filtration method for detecting microbial contamination
10/06/2011US20110244509 ApoIII and the Treatment and Diagnosis of Diabetes
10/06/2011US20110244508 Method for investigating the thrombocyte function of the blood
10/06/2011US20110244507 USE OF NEUREGULIN-ß AS AN INDICATOR AND/OR TARGET
10/06/2011US20110244506 Egfr dependent modulation of chemokine expression and influence on therapy and diagnosis of tumors and side effects thereof
10/06/2011US20110244505 Method for In Vitro Blood Testing
10/06/2011US20110244504 Biomarkers of inflammation in bruch's membrane of the human retina
10/06/2011US20110244503 System and Method for Anti-Cancer Drug Candidate Evaluation
10/06/2011US20110244502 Hormone responsive tissue culture system and uses thereof
10/06/2011US20110244501 Cancer stem cells
10/06/2011US20110244500 Gel electrophoresis method useful for resolution and characterization of nerve tissue ultra high molecular weight protein aggregates
10/06/2011US20110244499 Methods of enzymatic hydrolysis
10/06/2011US20110244498 Tyrosine kinase-inducible domains
10/06/2011US20110244497 Method for judging susceptibility of cancer cells to anthracycline anticancer agent and computer program
10/06/2011US20110244496 Hiv reverse transcriptase compositions and methods
10/06/2011US20110244488 Chitin-induced immune response based method for diagnosing allergic asthma in patients
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 3003